Listed-company information for individual investors
PureIR starts from annual reports and formal announcements, unfolding a company’s strengths, business character, financial progress and key risks on one source-linked page.
Independent and unofficial. Not investment advice.
About PureIR
PureIR lowers the barrier for individual investors to understand listed companies.
We start from formal disclosure: what the company does, where its advantages lie, how operations change and how financial performance develops. Every key number links back to its original source.
Published company profiles
01 · HKEX 01609
A sports-medicine medical-device company using four technology platforms to provide implants, surgical equipment and related consumables; first-half 2026 revenue was RMB163 million and its products had entered more than 3,000 hospitals in China.
Operations · 2026 interim results · PDF page 10 ↗
02 · HKEX 02190
Focused on the R&D, manufacturing and commercialisation of neurovascular and peripheral vascular interventional devices. First-half 2026 revenue was RMB632.036 million, gross margin was 73.4% and profit for the period was RMB179.110 million.
Financial highlights · 2026 interim results · PDF page 1 ↗
03 · HKEX 06699
A global service provider of clear aligner technology, production and sales.
Directors’ report · 2025 annual report · PDF page 28 ↗
04 · HKEX 02279
A leading medical group in China specialising in hair-related healthcare, offering one-stop services across hair transplantation, medical hair care, routine hair restoration and ancillary services.
Company profile · 2025 annual report · PDF page 3 ↗
05 · HKEX 02373
One of China’s largest beauty and health chain service groups, providing one-stop beauty and health services for women in high-tier cities through its dual beauty + dual wellness model.
Chairman’s statement · 2025 annual report · PDF page 12 ↗
06 · HKEX 02219
A leading ophthalmic medical service group in North China with a nationwide reputation, primarily providing consumer and basic ophthalmic services.
Corporate profile · 2025 annual report · PDF page 6 ↗
07 · HKEX 02158
YiduCore serves as its “AI Medical Brain” and the medical-intelligence infrastructure built for the entire healthcare industry chain.
YiduCore · FY2026 annual results · PDF page 3 ↗
Editorial method
Business and financial facts come from HKEX, company websites and formal announcements.
Published numbers include period, currency, unit, source URL and PDF page.
Company disclosure, external market data and PureIR summaries or calculations are labelled separately.
No ratings, target prices, undisclosed forecasts or unsourced judgements.